Unknown

Dataset Information

0

Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination.


ABSTRACT: SARS-CoV-2 mRNA vaccines have shown remarkable clinical efficacy, but questions remain about the nature and kinetics of T cell priming. We performed longitudinal antigen-specific T cell analyses on healthy SARS-CoV-2-naive and recovered individuals prior to and following mRNA prime and boost vaccination. Vaccination induced rapid antigen-specific CD4+ T cell responses in naive subjects after the first dose, whereas CD8+ T cell responses developed gradually and were variable in magnitude. Vaccine-induced Th1 and Tfh cell responses following the first dose correlated with post-boost CD8+ T cells and neutralizing antibodies, respectively. Integrated analysis revealed coordinated immune responses with distinct trajectories in SARS-CoV-2-naive and recovered individuals. Last, whereas booster vaccination improved T cell responses in SARS-CoV-2-naive subjects, the second dose had little effect in SARS-CoV-2-recovered individuals. These findings highlight the role of rapidly primed CD4+ T cells in coordinating responses to the second vaccine dose in SARS-CoV-2-naive individuals.

SUBMITTER: Painter MM 

PROVIDER: S-EPMC8361141 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rapid induction of antigen-specific CD4<sup>+</sup> T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination.

Painter Mark M MM   Mathew Divij D   Goel Rishi R RR   Apostolidis Sokratis A SA   Pattekar Ajinkya A   Kuthuru Oliva O   Baxter Amy E AE   Herati Ramin S RS   Oldridge Derek A DA   Gouma Sigrid S   Hicks Philip P   Dysinger Sarah S   Lundgreen Kendall A KA   Kuri-Cervantes Leticia L   Adamski Sharon S   Hicks Amanda A   Korte Scott S   Giles Josephine R JR   Weirick Madison E ME   McAllister Christopher M CM   Dougherty Jeanette J   Long Sherea S   D'Andrea Kurt K   Hamilton Jacob T JT   Betts Michael R MR   Bates Paul P   Hensley Scott E SE   Grifoni Alba A   Weiskopf Daniela D   Sette Alessandro A   Greenplate Allison R AR   Wherry E John EJ  

Immunity 20210813 9


SARS-CoV-2 mRNA vaccines have shown remarkable clinical efficacy, but questions remain about the nature and kinetics of T cell priming. We performed longitudinal antigen-specific T cell analyses on healthy SARS-CoV-2-naive and recovered individuals prior to and following mRNA prime and boost vaccination. Vaccination induced rapid antigen-specific CD4<sup>+</sup> T cell responses in naive subjects after the first dose, whereas CD8<sup>+</sup> T cell responses developed gradually and were variable  ...[more]

Similar Datasets

| S-EPMC10850212 | biostudies-literature
| S-EPMC7560895 | biostudies-literature
| S-EPMC9067342 | biostudies-literature
| S-EPMC5693336 | biostudies-literature
| S-EPMC11298648 | biostudies-literature
| S-EPMC9452889 | biostudies-literature
| S-EPMC8488660 | biostudies-literature
| S-EPMC9438359 | biostudies-literature
| S-EPMC8831839 | biostudies-literature